Arbejdsmarkedets Tillaegspension Increases Stake in HCA Healthcare, Inc. $HCA

Arbejdsmarkedets Tillaegspension grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 9.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 52,163 shares of the company’s stock after buying an additional 4,550 shares during the period. Arbejdsmarkedets Tillaegspension’s holdings in HCA Healthcare were worth $24,686,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Sumitomo Life Insurance Co. lifted its position in HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after buying an additional 20 shares in the last quarter. MJP Associates Inc. ADV increased its stake in shares of HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after acquiring an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC grew its holdings in shares of HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after purchasing an additional 21 shares during the period. Anchyra Partners LLC boosted its holdings in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after purchasing an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd raised its position in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $390.81 on Tuesday. The stock’s 50-day moving average is $396.68 and its two-hundred day moving average is $459.73. The company has a market cap of $86.70 billion, a price-to-earnings ratio of 13.44, a price-to-earnings-growth ratio of 1.29 and a beta of 1.12. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the prior year, the firm posted $6.45 earnings per share. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday, April 28th. Barclays lowered shares of HCA Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $496.00 to $427.00 in a report on Wednesday, July 8th. Leerink Partners dropped their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. KeyCorp dropped their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Truist Financial set a $413.00 price target on HCA Healthcare in a research report on Thursday, June 4th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $496.77.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.